Ahern T - Search Results

1

Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients with Diabetes: A Double-Blind Randomized Controlled Trial.

Lynch M, Malara A, Timoney I, Ahern T, Awdeh F, Sweeney C, Galligan M, Venckens S, Kelly G, Hughes R, O Apos Shea D, Doran P, Kirby B. Lynch M, et al. Among authors: ahern t. Dermatology. 2021;237(1):66-69. doi: 10.1159/000502130. Epub 2019 Aug 30. Dermatology. 2021. PMID: 31473741 Free article. No abstract available.

2

Dipeptidyl peptidase-4 inhibition and narrow-band ultraviolet-B light in psoriasis (DINUP): study protocol for a randomised controlled trial.

Lynch M, Ahern TB, Timoney I, Sweeney C, Kelly G, Hughes R, Tobin AM, O'Shea D, Kirby B. Lynch M, et al. Trials. 2016 Jan 15;17:29. doi: 10.1186/s13063-016-1157-z. Trials. 2016. PMID: 26767505 Free PMC article. Clinical Trial.

3

Sitagliptin for severe psoriasis.

Lynch M, Tobin AM, Ahern T, O'Shea D, Kirby B. Lynch M, et al. Among authors: ahern t. Clin Exp Dermatol. 2014 Oct;39(7):841-2. doi: 10.1111/ced.12408. Epub 2014 Aug 22. Clin Exp Dermatol. 2014. PMID: 25154439 No abstract available.

4

Sitagliptin and Narrow-Band Ultraviolet-B for Moderate Psoriasis (DINUP): A Randomised Controlled Clinical Trial.

Lynch M, Malara A, Timoney I, Vencken S, Ahern T, Awdeh F, Sweeney C, Galligan M, Kelly G, Hughes R, Murad A, Hambly R, O'Shea D, Doran P, Kirby B. Lynch M, et al. Among authors: ahern t. Dermatology. 2022;238(1):140-147. doi: 10.1159/000514494. Epub 2021 Apr 16. Dermatology. 2022. PMID: 33866313 Clinical Trial.

5

Glucagon-like peptide-1 analogue therapy for psoriasis patients with obesity and type 2 diabetes: a prospective cohort study.

Ahern T, Tobin AM, Corrigan M, Hogan A, Sweeney C, Kirby B, O'Shea D. Ahern T, et al. J Eur Acad Dermatol Venereol. 2013 Nov;27(11):1440-3. doi: 10.1111/j.1468-3083.2012.04609.x. Epub 2012 Jun 13. J Eur Acad Dermatol Venereol. 2013. PMID: 22691169

6

Adipokines, psoriasis, systemic inflammation, and endothelial dysfunction.

Lynch M, Ahern T, Sweeney CM, Malara A, Tobin AM, O'Shea D, Kirby B. Lynch M, et al. Among authors: ahern t. Int J Dermatol. 2017 Nov;56(11):1103-1118. doi: 10.1111/ijd.13699. Epub 2017 Aug 1. Int J Dermatol. 2017. PMID: 28762474 Review.

7

The dermatological consequences of obesity.

Tobin AM, Ahern T, Rogers S, Collins P, O'Shea D, Kirby B. Tobin AM, et al. Among authors: ahern t. Int J Dermatol. 2013 Aug;52(8):927-32. doi: 10.1111/j.1365-4632.2012.05624.x. Int J Dermatol. 2013. PMID: 23869924 Review.

8

Glucagon-like peptide-1 (GLP-1) and the regulation of human invariant natural killer T cells: lessons from obesity, diabetes and psoriasis.

Hogan AE, Tobin AM, Ahern T, Corrigan MA, Gaoatswe G, Jackson R, O'Reilly V, Lynch L, Doherty DG, Moynagh PN, Kirby B, O'Connell J, O'Shea D. Hogan AE, et al. Among authors: ahern t. Diabetologia. 2011 Nov;54(11):2745-54. doi: 10.1007/s00125-011-2232-3. Epub 2011 Jul 9. Diabetologia. 2011. PMID: 21744074 Free PMC article.

9

Liraglutide in combination with acitretin for severe recalcitrant psoriasis.

Reid CT, Tobin AM, Ahern T, O'Shea D, Kirby B. Reid CT, et al. Among authors: ahern t. Br J Dermatol. 2013 Jul;169(1):230-1. doi: 10.1111/bjd.12380. Br J Dermatol. 2013. PMID: 23834125 No abstract available.

10

Obesity-related chronic lymphoedema-like swelling and physical function.

O'Malley E, Ahern T, Dunlevy C, Lehane C, Kirby B, O'Shea D. O'Malley E, et al. Among authors: ahern t. QJM. 2015 Mar;108(3):183-7. doi: 10.1093/qjmed/hcu155. Epub 2014 Aug 1. QJM. 2015. PMID: 25086107

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters